Matthew Louis Mauriello is an Assistant Professor in the Department of Computer and Information Sciences at the University of Delaware , where he directs the Sensify Lab . He holds a PhD in Computer Science from the University of Maryland (2018) and completed postdoctoral work at Stanford University (School of Medicine, 2020; School of Public Policy & Environmental Engineering Department, 2019). Research interests span Human-Computer Interaction (HCI), Ubiquitous Computing, and User-Centered Design with applications in: Sustainability Human-Building Interaction Wearable Technology Personal Informatics Educational Game Design Mental Health Interventions Recent publications highlight trends in stress monitoring (skin-like biosensors, workplace wellbeing), energy auditing (thermography systems), and educational technology (block-based programming tools for teachers). His work appears in ACM CHI, ACM Human-Computer Interaction, and Building and Environment. Scientific awards include: Best Paper Honorable Mention, CHI 2016 Best Paper Honorable Mention, CHI 2015 Best of WebSci'18 Teaching at University of Delaware encompasses courses like Educational Game Design Operating Systems Advanced Web Technologies Computing for Social Good with a focus on project-based learning and systems thinking.
Dr. Diyi Yang is an Assistant Professor in the Computer Science Department at Stanford University. She leads the Social and Language Technologies (SALT) Lab, affiliated with the Stanford NLP Group, Stanford HCI Group, Stanford AI Lab (SAIL), and Stanford Human-Centered Artificial Intelligence (HAI). Her research focuses on socially aware natural language processing, large language models (LLMs), and human-AI interaction, aiming to improve human-human and human-computer communication through socially grounded AI systems. Education: Ph.D. in Language Technologies Institute, Carnegie Mellon University (2013–2019) B.S. in ACM Honored Class, Shanghai Jiao Tong University (2009–2013) Research Interests: Dr. Yang’s work bridges computational social science and NLP. She explores how AI can understand social contexts in language use and develop systems that respect cultural norms, ethical standards, and human values. Her lab’s projects include AI companions for skill training (e.g., Rehearsal Dialects), norm-aware LLMs (NormBank), and frameworks for human-AI collaboration (Co-Gym). Recent efforts address bias in AI, societal impacts of LLMs, and ethical evaluation of human-AI systems. Awards & Honors: 2024: Sloan Research Fellowship, ONR Young Investigator Award 2023: Adamic-Glance Young Distinguished Award (ICWSM), Kavli Fellow (NAS) 2022: NSF CAREER Award, Microsoft Research Faculty Fellow 2020: IEEE AI’s 10 to Watch Advising & Grants: Dr. Yang advises over 10 PhD students and postdocs, co-leading projects on LLM evaluation (SWE-bench/SWE-smith), human-AI ethics, and culturally aware NLP. Her research is supported by NSF, Amazon, DARPA, Google, and Stanford’s HAI initiative. Labs & Teams: The SALT Lab collaborates across disciplines, with projects spanning computer science, linguistics, and social sciences. Current initiatives include developing AI tools for mental health support (AI Partner & Mentor) and auditing societal impacts of LLMs.
Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.
Daniel Epstein is an Associate Professor in the Department of Informatics at the University of California, Irvine (UCI), where he leads the Personal Informatics Everyday (PIE) Lab. He holds a courtesy appointment in the Department of Computer Science and is affiliated with the Connected Learning Lab, Institute for Future Health, and Accessibility Research Collective. Epstein earned his Ph.D. in Computer Science & Engineering from the University of Washington and a B.S. in Computer Science from the University of Virginia. His research focuses on how personal tracking technology can better serve diverse users' needs, emphasizing ethical design, health equity, and long-term user engagement. Notable areas include pregnancy tracking, wearable technology for children and ADHD management, and AI-driven health chatbots. Epstein has received grants from NSF, Snap Inc., and UCI programs, totaling over $650k in funding. Epstein's work bridges HCI and health informatics, with over 60 peer-reviewed publications. He advises six Ph.D. students and has mentored numerous undergraduates. Awards include the ACM Senior Member distinction (2025), CHI Best Paper (2023), and NSF CAREER Award (2023). Professional service includes program committees for CHI, CSCW, and UbiComp, plus leadership roles in workshops like the Workgroup on Interactive Systems in Healthcare (WISH). Beyond academia, Epstein enjoys hiking, collecting turtle figures, and advocating for accessible technology.
Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.
Maja J Matarić is the Chan Soon-Shiong Chaired and Distinguished Professor of Computer Science at the University of Southern California's Viterbi School of Engineering, with courtesy appointments in Neuroscience and Pediatrics. She serves as founding director of the USC Robotics and Autonomous Systems Center, co-director of the USC Robotics Research Lab, and Principal Scientist at Google DeepMind. Previously, she held leadership roles as USC's interim Vice President of Research (2020-2021) and Vice Dean for Research (2006-2019). Her educational background includes: PhD in Computer Science and Artificial Intelligence from MIT (1994) MS in Computer Science from MIT (1990) BS in Computer Science from University of Kansas (1987) Matarić pioneers Socially Assistive Robotics (SAR) , a field her lab named, focusing on human-robot interaction that provides assistance through social rather than physical support. Her research targets critical health and wellness challenges including post-stroke rehabilitation, autism spectrum disorder therapy, cognitive exercises for Alzheimer's patients, ADHD academic support, and mental health interventions. She develops systems modeling user engagement, personality, and motivation, with extensive real-world deployments in schools, rehabilitation centers, and homes. Analysis of her recent publications reveals dominant themes in cognitive health robotics (2025 CHI paper on LLM-powered elder care), pediatric assistive technology (2025 IDC speech therapy review), and adaptive preference modeling (2025 HRI contrastive learning work). Her research consistently bridges machine learning with human-centered design for vulnerable populations. Major scientific recognition includes: ACM Athena Lecturer Award (2024) ACM Eugene L. Lawler Humanitarian Award (2024) ACM Fellow (2020) Presidential Mentoring Award (2011) Multiple society fellowships (AAAS, IEEE, AAAI) As a dedicated mentor, Matarić has championed underrepresented groups through CRA-W, placing numerous women in faculty positions. She leads USC Viterbi's K-12 STEM Outreach Program serving low-income Los Angeles schools and authored The Robotics Prime for student education. Her research has secured significant funding enabling real-world technology transfer, with documented impact in rehabilitation centers and homes through deployable SAR systems. Her Robotics Research Lab at USC drives innovation in embodied AI, with current projects spanning LLM-integrated elder care robots, ADHD academic companions, and autism therapy systems. The lab emphasizes co-design with end-users and rigorous real-world validation across diverse populations.
Dr. Kaya de Barbaro is an Associate Professor in the Department of Psychology at the University of Texas at Austin (College of Liberal Arts). She holds a Ph.D. from the University of California San Diego. Her research focuses on bridging computer science and developmental/clinical psychology, particularly maternal mental health and infant social-emotional development. She directs the Daily Activity Lab, which uses mobile/wearable sensors and machine learning to analyze real-world interactions, aiming to develop just-in-time interventions for new mothers. Key research areas include maternal-infant dynamics, physiological synchronization, and the impact of environmental chaos on development. She has pioneered methods for analyzing high-density data, such as Granger causality and machine learning algorithms to detect behaviors like crying and holding. Recent work emphasizes leveraging ecological momentary assessment surveys and 24-hour LENA audio recordings to understand proximal mechanisms of development. Dr. de Barbaro teaches Psychology 333D (Introduction to Developmental Psychology) and has developed curricula for both in-person and online formats. She is actively involved in training students through the Eureka program at UT Austin. Her lab collaborates on tools like chatbots for postpartum mental health and has published extensively on sensor-based methodologies in developmental science.
Tim Althoff is an Associate Professor at the Paul G. Allen School of Computer Science & Engineering, University of Washington, specializing in Artificial Intelligence and Human-Centered Computing. His research focuses on behavioral data science, combining Data Science Natural Language Processing Social Computing Human-Centered AI Ethics & Fairness to extract insights about health and well-being. Recent publications highlight advancements in: Mental health support through AI Wearable sensor health monitoring Online community analysis Reproducibility in data science Public health interventions with notable papers in ACL, Nature Machine Intelligence, and NeurIPS. Scientific recognition includes: ACL 2023 Outstanding Paper Award WWW 2021 Best Paper Award Double ICWSM 2021 Best Paper Awards SIGKDD Dissertation Award 2019 Fulbright Scholarship German National Merit Foundation Actively mentoring postdoctoral researchers and seeking PhD students in areas like neural representation learning, NLP applications to psychology, and mobile health technologies through his Behavioral Data Science Group .
Hang Lu is a Professor and holds the Cecil J. "Pete" Silas Chair of Chemical & Biomolecular Engineering at the Georgia Institute of Technology. Dr. Lu also holds a Love Family Professorship and leads the Lµ Fluidics Group, which focuses on engineering microfluidic systems and machine learning tools to address complex questions in neuroscience, developmental biology, and cell biology that are difficult to address with conventional techniques. Dr. Lu's research lies at the intersection of engineering and biology, with primary interests including: Microfluidic systems for high-throughput screens and image-based genetics and genomics Systems biology: large-scale experimentation and data mining Microtechnologies for optical stimulation and optical recording Big data, machine vision, and automation Developmental neurobiology, behavioral neurobiology, and systems neuroscience Cancer biology, immunology, embryonic development, and stem cells Her laboratory engineers microfluidic devices and BioMEMS to study neuroscience, genetics, cancer biology, and biotechnology. These miniaturized Lab-on-a-chip tools operate at scales comparable to biological systems, leveraging unique micro and nano-scale phenomena to gather large-scale quantitative data about complex biological systems. Current projects include Microfluidics for Life Sciences, Optical Neuron Recordings and Manipulations, Machine Learning Tools for Neuroscience, Measuring and Modeling Behavior, and High-throughput, High-content Cell-based Assays. Analysis of Dr. Lu's recent publications (2024-2025) reveals a strong trend toward integrating microfluidics with advanced computational methods: Development of deep learning frameworks for biological image analysis Advanced neuron tracking and functional imaging techniques Non-invasive characterization of 3D organoid cultures Sophisticated neuromechanical modeling of locomotion Microfluidic temperature control systems for in vivo studies Label-free imaging pipelines for neural development Dr. Lu's significant professional honors include: Cecil J. "Pete" Silas Chair of Chemical & Biomolecular Engineering Love Family Professorship The Lµ Fluidics Group actively mentors students and postdocs, currently accepting new postdoctoral researchers. The lab receives substantial funding for interdisciplinary projects at the engineering-biology interface, with research implications spanning fundamental biological understanding to therapeutic development. The group operates within Georgia Tech's School of Chemical & Biomolecular Engineering, with specialized facilities for microfluidic device fabrication, biological experimentation, and advanced imaging, maintaining strong collaborative ties across engineering, neuroscience, and biological disciplines.
Lori Escallier, PhD, RN, CPNP-PC, FAAN is a Professor and Dean at the College of Nursing, Downstate Health Sciences University. With over 36 years of experience in nursing education, she is recognized nationally for developing innovative mentorship models and educational engagement strategies that have significantly impacted underrepresented and minority nursing students. Academic Qualifications BSN from Salve Regina College (1980) MSN from SUNY Stony Brook (1988) PhD from Adelphi University (1995) Her research focuses on diversifying the nursing workforce, addressing healthcare disparities, and leveraging veteran experiences in academic settings. She pioneered the Veteran to BS Program, translating military experience into academic credit, and co-authored the award-winning RWJF/AACN Transition to Practice Toolkit. Scientific Awards RWJF Innovation Award Above and Beyond Award (2015) Fellow of the American Academy of Nursing (FAAN) Her publications emphasize nurse mentorship, veteran healthcare transitions, and digital tools for reducing disparities. She has secured over $9M in grants from RWJF and HRSA to support these initiatives.
Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.
Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .
Pasquale Bottalico serves as Associate Professor in the Department of Speech and Hearing Science at the University of Illinois, with dual appointments as Associate Professor at the Center for Latin American and Caribbean Studies and Affiliate Faculty in the School of Music. His unique interdisciplinary profile bridges engineering, music performance, and speech science, reflecting his dual academic training and professional artistry. His educational foundation includes: Bachelor's in Telecommunications Engineering from Univeristà Mediterranea di Reggio Calabria, Italy Concurrent Opera Singing degree from F. Cilea Music Academy, Reggio Calabria Master's in Telecommunications Engineering from Politecnico di Torino, Italy Ph.D. in Metrology specializing in acoustics measurement uncertainty and classroom acoustics Dr. Bottalico's research centers on vocal load quantification and professional voice techniques , with significant contributions to understanding vocal fatigue in teachers and singers. His work spans Speech Intelligibility in educational environments, Room Acoustics for performance and learning spaces, and Musical Acoustics of historical vocal styles. A distinctive thread throughout his research examines how acoustic conditions modulate voice production and perception, increasingly incorporating virtual reality and bone conduction technologies for innovative assessment and intervention approaches. His Colombian vocal health study demonstrates cross-cultural applications of his work. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) The impact of noise and dysphonia on children's speech processing in educational settings, using multimodal assessment including EEG; (2) Virtual reality applications for voice production research and therapeutic intervention; (3) Cross-cultural validation of vocal fatigue metrics and development of biofeedback systems. His work consistently bridges engineering precision with clinical applicability, particularly for professional voice users in challenging acoustic environments. No scientific awards were documented in the available information. While specific advising relationships aren't detailed, his research collaborations span international institutions including Colombian and Italian universities, suggesting graduate mentorship in interdisciplinary projects. No grant information was provided, though his systematic reviews and cross-cultural studies imply externally funded research activities. Though no dedicated laboratory is specified, his virtual reality voice studies and acoustic parameter assessments suggest affiliations with audio engineering facilities and voice clinics, likely through the Speech and Hearing Science department's research infrastructure.
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
Ting Lu is an Associate Professor at the University of Illinois at Urbana-Champaign in the School of Biomedical and Translational Sciences, focusing on microbial synthetic biology and systems biology. Their research bridges biology, engineering, and physics to reprogram cellular functionalities through gene regulatory networks. Ph.D. in Biophysics, University of California at San Diego (2007) B.S. in Physics, Zhejiang University (2002) Ting Lu's work explores microbial ecosystems, synthetic gene circuits, and their applications in biotechnology and medicine. By combining experimental approaches with mathematical modeling, they investigate bacterial communication networks, metabolic pathways, and spatial dynamics in microbial communities. Selected research trends include microbial consortia engineering for bioremediation and bioproduction, complexity reduction in microbiomes, and predictive modeling of synthetic gene networks. Their publications span high-impact journals such as Nature Communications , Nature Chemical Biology , and eLife . Fellow, American Institute for Medical and Biological Engineering (2022) Future Insight Prize (2021) Donald Biggar Willett Faculty Scholar (UIUC) (2020) NIH Maximizing Investigators' Research Award (2019) NSF CAREER Award (2015) AHA National Scientist Development Grant (2012) Ting Lu's lab has received grants from NIH, NSF, ONR, and industry partners. They offer undergraduate research opportunities in synthetic and systems biology, and teach advanced courses such as BIOE 430 - Intro Synthetic Biology and BIOE 432 - Systems Biology .
